News

2-D Echo Is Inadequate Cardiomyopathy Screen in Childhood Cancer Survivors


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

This study was supported by the American Society of Clinical Oncology and the American Lebanese-Syrian Associated Charities. Dr. Armstrong’s associates reported ties to General Electric and Philips Healthcare.

Pages

Recommended Reading

Act 2 Opens for Stem-Cell Heart Treatments
MDedge Cardiology
Independent Study Confirms Higher Riata ICD Lead Failure Rate
MDedge Cardiology
ACC Urges Shift to Patient-Centered Care
MDedge Cardiology
Mechanical Circulatory Support for Select Patients Nears Transplant Survival Rates
MDedge Cardiology
Longer ICD Detection Window Reduces Inappropriate Shocks
MDedge Cardiology
Shift From Atrial Overdrive Pacing for AF Prevention Urged
MDedge Cardiology
ICDs' Mortality Benefit Persists Up to 12 Years
MDedge Cardiology
What's the Dose?
MDedge Cardiology
FDA Announces Recall of Cardiac Diagnostic Tests
MDedge Cardiology
Studies Clash on Cardiac Effects of TKIs in Kidney Cancer
MDedge Cardiology